In this report we describe chd1 mutant alleles and show that the CHD1 chromatin-remodeling factor is important for wing development and fertility. While CHD1 colocalizes with elongating RNA polymerase II (Pol II) on polytene chromosomes, elongating Pol II can persist on chromatin in the absence of CHD1. These results clarify the roles of chromatin remodelers in transcription and provide novel insights into CHD1 function.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206105 | PMC |
| http://dx.doi.org/10.1534/genetics.107.079038 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A direct interaction between the Chd1 CHCT domain and Rtf1 controls Chd1 distribution and nucleosome positioning on active genes.
bioRxiv
December 2024
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA USA.
The nucleosome remodeler Chd1 is required for the re-establishment of nucleosome positioning in the wake of transcription elongation by RNA Polymerase II. Previously, we found that Chd1 occupancy on gene bodies depends on the Rtf1 subunit of the Paf1 complex in yeast. Here, we identify an N-terminal region of Rtf1 and the CHCT domain of Chd1 as sufficient for their interaction and demonstrate that this interaction is direct.
View Article and Find Full Text PDFDiscovery of CHD1 Antagonists for PTEN-Deficient Prostate Cancer.
J Med Chem
November 2024
Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
CHD1 is a chromodomain-helicase DNA-binding protein that preferentially recognizes di- and trimethylated lysine 4 on histone H3 (H3K4me2/3). Genetic studies have established CHD1 as a synthetic lethal target in phosphatase and tensin homologue (PTEN)-deficient cancers. Despite this attractive therapeutic link, no inhibitors or antagonists of CHD1 have been reported to date.
View Article and Find Full Text PDFIdentification and functional characteristics of CHD1L gene variants implicated in human Müllerian duct anomalies.
Biol Res
September 2024
Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 17 QiHeLou Street, Dongcheng District, Beijing, 100006, China.
Article Synopsis
- Müllerian duct anomalies (MDAs) are congenital reproductive tract disorders in females, with recent advancements in whole-exome sequencing (WES) providing new insights into their genetic causes, though many mechanisms remain unclear.
- In a study involving 97 MDAs patients, researchers identified two novel heterozygous CHD1L variants linked to these anomalies, with variants' pathogenicity confirmed through functional assays and molecular simulations.
- The study found that the identified variants impaired CHD1L function, affecting protein localization and interactions, leading to a calculated contribution of CHD1L variants to MDAs at 4.12%.
Finish the unfinished: Chd1 resolving hexasome-nucleosome complex with FACT.
Mol Cell
September 2024
School of Biomedical Sciences, The University of Hong Kong, Hong Kong SAR, China. Electronic address:
In this issue of Molecular Cell, Engeholm et al. present cryo-EM structures of the chromatin remodeler Chd1 bound to a hexasome-nucleosome complex, an intermediate state during transcription either with or without FACT to restore the missing H2A-H2B dimer. These two binding modes reveal how Chd1 and FACT cooperate in nucleosome re-establishment during transcription.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!